214 related articles for article (PubMed ID: 37511763)
1. Breast Cancer Surrogate Subtype Classification Using Pretreatment Multi-Phase Dynamic Contrast-Enhanced Magnetic Resonance Imaging Radiomics: A Retrospective Single-Center Study.
Kovačević L; Štajduhar A; Stemberger K; Korša L; Marušić Z; Prutki M
J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511763
[TBL] [Abstract][Full Text] [Related]
2. Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning.
Sheng W; Xia S; Wang Y; Yan L; Ke S; Mellisa E; Gong F; Zheng Y; Tang T
Front Oncol; 2022; 12():964605. PubMed ID: 36172153
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
4. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
Front Oncol; 2022; 12():905551. PubMed ID: 35814460
[TBL] [Abstract][Full Text] [Related]
5. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
[TBL] [Abstract][Full Text] [Related]
6. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
Front Oncol; 2021; 11():706733. PubMed ID: 34490107
[TBL] [Abstract][Full Text] [Related]
7. Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Leithner D; Horvat JV; Marino MA; Bernard-Davila B; Jochelson MS; Ochoa-Albiztegui RE; Martinez DF; Morris EA; Thakur S; Pinker K
Breast Cancer Res; 2019 Sep; 21(1):106. PubMed ID: 31514736
[TBL] [Abstract][Full Text] [Related]
8. Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.
Caballo M; Sanderink WBG; Han L; Gao Y; Athanasiou A; Mann RM
J Magn Reson Imaging; 2023 Jan; 57(1):97-110. PubMed ID: 35633290
[TBL] [Abstract][Full Text] [Related]
9. Radiomics Analysis of Contrast-Enhanced Breast MRI for Optimized Modelling of Virtual Prognostic Biomarkers in Breast Cancer.
Polat DS; Xi Y; Hulsey K; Lewis M; Dogan BE
Eur J Breast Health; 2024 Apr; 20(2):122-128. PubMed ID: 38571687
[TBL] [Abstract][Full Text] [Related]
10. DCE-MRI Radiomics Analysis in Differentiating Luminal A and Luminal B Breast Cancer Molecular Subtypes.
Lafcı O; Celepli P; Seher Öztekin P; Koşar PN
Acad Radiol; 2023 Jan; 30(1):22-29. PubMed ID: 35595629
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
12. Molecular subtypes of breast cancer identified by dynamically enhanced MRI radiomics: the delayed phase cannot be ignored.
Huang G; Du S; Gao S; Guo L; Zhao R; Bian X; Xie L; Zhang L
Insights Imaging; 2024 May; 15(1):127. PubMed ID: 38816553
[TBL] [Abstract][Full Text] [Related]
13. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
Fan M; Li H; Wang S; Zheng B; Zhang J; Li L
PLoS One; 2017; 12(2):e0171683. PubMed ID: 28166261
[TBL] [Abstract][Full Text] [Related]
14. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
[TBL] [Abstract][Full Text] [Related]
15. Prediction Breast Molecular Typing of Invasive Ductal Carcinoma Based on Dynamic Contrast Enhancement Magnetic Resonance Imaging Radiomics Characteristics: A Feasibility Study.
Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
Front Oncol; 2022; 12():799232. PubMed ID: 35664741
[TBL] [Abstract][Full Text] [Related]
16. Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics.
Leithner D; Mayerhoefer ME; Martinez DF; Jochelson MS; Morris EA; Thakur SB; Pinker K
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545851
[TBL] [Abstract][Full Text] [Related]
17. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features.
Ma W; Zhao Y; Ji Y; Guo X; Jian X; Liu P; Wu S
Acad Radiol; 2019 Feb; 26(2):196-201. PubMed ID: 29526548
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
20. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
Demircioglu A; Grueneisen J; Ingenwerth M; Hoffmann O; Pinker-Domenig K; Morris E; Haubold J; Forsting M; Nensa F; Umutlu L
PLoS One; 2020; 15(6):e0234871. PubMed ID: 32589681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
